Go to deals
Private Equity | Consumer & Retail | TMT

The management of Keesing has successfully invested in the company alongside BC Partners

The management team of Keesing Media Group B.V. has invested alongside BC Partners in the acquisition of the company from Ergon Capital and Mediahuis.

Keesing is Europe’s leading company in developing and publishing puzzle content. The company was founded in the Netherlands over 100 years ago and currently has a presence in over 40 countries. It offers games in both printed and digital format to consumers who want to entertain themselves and challenge their brain. Keesing is the market leader in countries such as France, the Netherlands, Sweden and Spain. International brands include Denksport, Sport Cérébral and Megastar.

Founded in 1986, BC Partners is an investment firm investing in larger businesses in Europe and North America, through offices in London, Hamburg and New York. BC Partners currently invests from its tenth private equity fund.

Ergon Capital is a mid-market private equity firm that operates from six different locations. The firm focuses on investments in the Benelux, France, Germany, Italy and Spain. It was founded in 2005 in Belgium and is currently investing out of its fourth fund.

Oaklins’ team in the Netherlands acted as financial advisor to the management of Keesing in this transaction.

Talk to the deal team

 Bas  Stoetzer

Bas Stoetzer

Partner
Amsterdam, Netherlands
Oaklins Netherlands
 Niels  Vermuë

Niels Vermuë

Associate Director
Amsterdam, Netherlands
Oaklins Netherlands

Related deals

Conzylum has been acquired by EPAM Systems, Inc.
TMT

Conzylum has been acquired by EPAM Systems, Inc.

Conzylum has ben sold to EPAM Systems, Inc. (EPAM).

Learn more
White Lab has acquired Testing
Private Equity | Business Support Services

White Lab has acquired Testing

White Lab Srl. has acquired Testing Srl.

Learn more
Cara Care has been acquired by Mahana Therapeutics
Private Equity | Healthcare | TMT

Cara Care has been acquired by Mahana Therapeutics

Mahana Therapeutics Inc., renowned for its pioneering digital treatments targeting chronic health issues, has recently finalized the acquisition of Cara Care (HiDoc Technologies GmbH). Cara Care stands out as a premier digital health platform and an official digital health application (DiGA) dedicated to enhancing gut health. This acquisition, supported by key investors Lux Capital and Jazz Ventures Partners, perfectly aligns with Mahana’s expansion strategy.

Learn more